Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

This publication has 57 references indexed in Scilit:

• β ₂ -Glycoprotein 1–Dependent Anticardiolipin Antibodies and Risk of Ischemic Stroke and Myocardial Infarction
  Stroke, 2001
• International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop
  Arthritis & Rheumatism, 1999
• Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome
  Rheumatology, 1996
• Comparison of an enzyme‐linked immunosorbent assay for antibodies to β₂‐glycoprotein I and a conventional anticardiolipin immunoassay
  Arthritis & Rheumatism, 1996
• Antibodies to Phospholipid-Binding Plasma Proteins and Occurrence of Thrombosis in Patients with Systemic Lupus Erythematosus
  Clinical Immunology and Immunopathology, 1996
• Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome?
  Lupus, 1995
• Anti‐annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody
  American Journal of Hematology, 1994
• The “Primary” Antiphospholipid Syndrome
  Medicine, 1989
• Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients
  Medicine, 1989
• Anticardiolipin response in acute infections
  Clinical Immunology and Immunopathology, 1986